Reduction of allogeneic red blood cell transfusions in patients undergoing elective, noncardiac, nonvascular surgery
PROCRIT® is indicated to reduce the need for allogeneic RBC transfusions among patients with perioperative hemoglobin >10 g/dL to ≤13 g/dL who are at high risk for perioperative blood loss from elective, noncardiac, nonvascular surgery. PROCRIT® is not indicated for patients who are willing to donate autologous blood preoperatively.
Patient scheduled for elective, noncardiac, nonvascular surgery
*Other causes of anemia may include vitamin deficiency, metabolic or chronic inflammatory conditions, bleeding, etc.
PROCRIT® offers the convenience of 2 dosing options—weekly1…
- PROCRIT® Prescribing Information. Janssen Products, LP.